Secondary cancers in breast cancer survivors. A two-centre study.

However, when analysing the timeline to the emergence of a second malignancy, there emerged a suggestive trend associated with combination therapies, such as the concurrent use of chemotherapy and hormone therapy.

also in 203 other papers